Rare cancers: A growing focus of early-stage clinical trials
IMAGE: Dr. Jun Sato of the National Cancer Center Hospital, Japan, lead author of the latest research. view more Credit: ©European Society for Medical Oncology Paris, France, 25 February 2019 – The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumour types receive increasing…